Q.21 In hepatocellular disease
1. only conjugated bilirubin levels are increased
2. only unconjugated bilirubin levels are increased
3. both conjugated and unconjugated bilirubin levels are increased
4. conjugated bilirubin levels are increased and unconjugated bilirubin levels are decreased
In hepatocellular disease, both conjugated and unconjugated bilirubin levels are typically increased due to impaired liver function affecting uptake, conjugation, and excretion.
Hepatocellular diseases, such as viral hepatitis, alcoholic hepatitis, or cirrhosis, damage hepatocytes, disrupting bilirubin metabolism at multiple stages: uptake of unconjugated bilirubin, its conjugation to the direct form, and excretion into bile. This leads to accumulation of both unconjugated (indirect) and conjugated (direct) bilirubin in serum, often with elevated transaminases like ALT/AST indicating hepatocyte injury. Total bilirubin rises, with a mixed pattern where unconjugated predominates early but both elevate as dysfunction worsens.
Correct Answer
Option 3: Both conjugated and unconjugated bilirubin levels are increased.
Liver cell damage impairs all bilirubin handling steps, causing mixed hyperbilirubinemia.
Option Explanations
| Option | Statement | Explanation |
|---|---|---|
| 1 | Only conjugated bilirubin levels are increased | Incorrect. This pattern fits obstructive (post-hepatic) jaundice from bile duct blockage, where conjugated bilirubin backs up due to excretion failure, not hepatocyte damage. |
| 2 | Only unconjugated bilirubin levels are increased | Incorrect. Pure unconjugated rise occurs in pre-hepatic causes like hemolysis (e.g., sickle cell) or conjugation defects (e.g., Gilbert syndrome), where liver uptake/conjugation fails but excretion works. |
| 3 | Both conjugated and unconjugated bilirubin levels are increased | Correct. Hepatocellular injury (e.g., hepatitis, cirrhosis) disrupts uptake, conjugation, and excretion, elevating both forms; severe cases show high total bilirubin (>4 mg/dL). |
| 4 | Conjugated bilirubin levels are increased and unconjugated bilirubin levels are decreased | Incorrect. No mechanism in liver disease lowers unconjugated bilirubin; both rise or unconjugated predominates if mild, but decreases are rare and not characteristic. |
Clinical Relevance
Mixed hyperbilirubinemia in hepatocellular disease signals poor prognosis, especially if bilirubin >20 mg/dL in acute failure. Diagnosis uses labs (mixed bilirubin, high ALT/AST) and imaging; treat underlying cause like antivirals for hepatitis. For exams, distinguish from pre-hepatic (unconjugated only, normal enzymes) and post-hepatic (conjugated only, high ALP).
